Reliable Detection of Group B Streptococcus in the Clinical Laboratory
- PMID: 28659318
- PMCID: PMC5648696
- DOI: 10.1128/JCM.00582-17
Reliable Detection of Group B Streptococcus in the Clinical Laboratory
Abstract
Group B streptococcus (GBS) is a leading cause of invasive neonatal infections and a significant pathogen in immunocompromised adults. Screening to detect GBS colonization in pregnant women determines the need for antibiotic prophylaxis in that pregnancy. Efficient determination of the GBS colonization status of pregnant women is crucial. Methods that maximize the probability of GBS recovery are needed. The availability of technologies such as matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS), molecular techniques, and chromogenic culture media, including Granada-type media, have changed the scenario for GBS detection and identification. This review presents and evaluates novel diagnostic tools, as well as classic identification techniques, for GBS species determination.
Keywords: GBS; group B streptococcus.
Copyright © 2017 American Society for Microbiology.
References
-
- Edwards MS, Nizet V, Baker CJ. 2016. Group B streptococcal infections, p 411–456. In Wilson CB, Nizet V, Maldonado Y, Klein JO, Remington JS (ed), Remington and Klein's infectious diseases of the fetus and newborn infant. Elsevier Saunders, Philadelphia, PA.
-
- Fry RM. 1938. Fatal infections by hemolytic streptococcus group B. Lancet i:199–201.
-
- Verani JR, McGee L, Schrag SJ. 2010. Prevention of perinatal group B streptococcal disease–revised guidelines from CDC. MMWR Recomm Rep 59(RR-10):1–36. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical